Product Information
DESMOPRESSIN AC 4 MCG/ML VIAL is a generic product labeled by XGen Pharmaceuticals DJB, Inc., priced at $19.1479 per ML under NDC 39822620002. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Sep 17, 2020. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 ug/mL
Manufacturer
XGen Pharmaceuticals DJB, Inc.NDC
39822620002
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
DESMOPRESSIN ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210223FDA Approved
9/17/2020
TE Code
AP
On Market Since
3/22/2024
Pharmacological Classes
Price Statistics
The NADAC for DESMOPRESSIN AC 4 MCG/ML VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 39.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1479 per ML |
|---|---|
| All-time high | $32.3369 (Jun 12, 2024) |
| All-time low | $17.7125 (Dec 17, 2025) |
| 52-week high | $20.8637 |
| 52-week low | $17.7125 |
| Median price | $19.4503 |
| Average price | $21.5802 |
| Largest weekly change | -19.6% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
XGen Pharmaceuticals DJB, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desmopressin acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor VIII Activator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESMOPRESSIN AC 4 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DESMOPRESSIN AC 4 MCG/ML VIAL, manufactured by XGen Pharmaceuticals DJB, Inc., is $19.1479 per ML (NDC 39822620002), effective Sep 30, 2026.
How has the price of DESMOPRESSIN AC 4 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DESMOPRESSIN AC 4 MCG/ML VIAL has declined 39.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DESMOPRESSIN AC 4 MCG/ML VIAL?
Since Apr 17, 2024, the NADAC for DESMOPRESSIN AC 4 MCG/ML VIAL has ranged from a low of $17.7125 (Dec 17, 2025) to a high of $32.3369 (Jun 12, 2024), with a median of $19.4503 per ML.
Are there cheaper alternatives to DESMOPRESSIN AC 4 MCG/ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DESMOPRESSIN 40 MCG/10 ML VIAL, is $18.1179 per ML — about 5% below DESMOPRESSIN AC 4 MCG/ML VIAL.
Who manufactures DESMOPRESSIN AC 4 MCG/ML VIAL?
DESMOPRESSIN AC 4 MCG/ML VIAL (NDC 39822620002) is labeled by XGen Pharmaceuticals DJB, Inc., and CMS classifies it as a generic product.